"Payviders" are responsible for the cost of avoidable readmissions and emergency room visits, but they lose sight of patients once they go home.
|Articles|June 1, 2003
Eye on the Alps
Author(s)Michael T. McCue
If there's one thing Regina Herzlinger understands, it's the relationship between risk and benefit. Her home in Belmont, Mass., sits high on a hill and offers a stunning view of the Boston skyline across the Charles River. But there was a price to pay for that unobstructed view, and after a very frightening near-accident involving her car and some black ice, it didn't take Regina and her husband George-with doctorates in business and physics, respectively-long to realize that the risks were too high.
Advertisement
Advertisement
Related to this article
Jenny Goins, interim head of the National Alliance of Healthcare Purchaser Coalitions, says employers need the same visibility into medical benefits that a new Department of Labor rule gives them into PBM compensation.
Only 19% of community oncologists use AI predictive models. Prerna Mewawalla, M.D., outlines six ways AI can already help in myeloma care.
Jamilia Sherls, DNP, says health systems should track vaccine coverage closely and look to AAP schedules if federal guidance isn't evidence-based.
Model N's Jesse Mendelsohn explains why drug manufacturers argued that a 340B rebates instead of upfront discounts will avoid an overlapping maximum fair price and 340B discounts
People with ADHD had a 70% higher risk of death from any cause in a 19-study meta-analysis, with excess deaths from suicide, injury and natural causes.
Bronchiectasis affected 221.6 per 100,000 people in the U.S. over five years, which is higher than earlier national estimates, according to a study published in CHEST.
Cepheid’s Xpert Respiratory Panel, which tests one swab for nine viruses and four bacteria, is now certified for sale in Europe under the IVDR.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The payvider blind spot: When clinical visibility ends but financial risk continues
2
Quick Q&A: Jenny Goins on bringing PBM-style transparency to the medical side of benefits
3
Bronchiectasis is more common in the U.S. than a decade ago, study finds
4
Six jobs for AI in myeloma care, from Prerna Mewawalla, M.D.
5